Overview of your organisation

Amasu Technologies Pty (Ltd) applies strategic thinking to develop innovative devices that address global health problems. We are a proudly South African biotechnology company (founded in 2017) that specializes in the development, manufacturing and prototyping of diagnostic devices for a wide range of medical applications. In addition, we offer contract prototyping services to academic and research organizations interested in medical device development or business development. We draw inspiration from the fact that the field of Biotechnology is still new to South Africa and there are very few South African Biotechnology companies serving this space. Therefore, through our local networks, we embrace partnerships and collaborations with international companies that are seeking to penetrate the African markets. At the heart of this is our desire to promote technology and business transfer with international organizations that are driven by the same goal, while providing employment opportunities to South Africans at different levels of expertise and socioeconomic backgrounds. Our team consists of a diverse group of experts in: Microfluidics (PDMS and paper-based); Lateral Flow devices; Photolithography; Softlithography; Chemistry, Microbiology, Virology; Infectious Diseases; Prototyping; Biotechnology, Bioengineering; and Business Development.

Our mission is to: 1. To develop innovative devices that address global health problems 2. To transform the Biotechnology landscape of South Africa through innovation, consultancy & collaborations.

Resources
Amasu Technologies offers a range of services centered around our philosophy of innovation and collaboration. These services include technology development in:

1. Diagnostic development and optimization
2. Biomarker screening, identification and validation
3. Assay conceptualization, development and optimization
4. Consultation: We can help you convert academic research into a commercially viable product
5. Rapid prototyping and proof of concepts: We can help develop proof of concepts and prototypes from academia research outputs
6. Intellectual Property (IP) generation: We facilitate the conversion of research outputs such as publications into IP (e.g. patents)
7. Our facility can produce up to 1,000 lateral flow test kits per week. This service is instrumental for South African and international organizations that are planning to perform clinical validations or certification of their wide range of test kits
Institution type
Other
Academic department involvement
Public Universities; Medical Sciences; Life Sciences; TVET Colleges; Veterinary departments; Biochemistry; Chemistry; Analytical Chemistry; Immunology; Microbiology; Environmental Science
Researcher involvement
1. Dr Tawanda Mandizvo: Microfluidics; Virology; Lateral Flow Devices; Infectious Diseases; Microbiology; Monoclonal Antibodies; Microfabrication; Veterinary Diagnostics; Molecular Biology

2. Dr Ian Mbano: Microfluidics; Lateral Flow Devices; Infectious Diseases; Microbiology; Microfabrication; Veterinary Diagnostics; Tuberculosis; Molecular Biology; Biotechnology

3. Dr Tafara Kunota: Microfluidics; Lateral Flow Devices; Infectious Diseases; Microbiology; Microfabrication; Veterinary Diagnostics; Tuberculosis; Bioengineering; Computational Physics

4. Dr Ashley Pretorius: Biomathematics, Bioinformatics, and Computational Biology
Physical address

Suite 4, Block A, First Floor
43/45 Ridge Road
Hillcrest Park
Durban
South Africa

Street name and number
43/45 Ridge Road
Industry
Human health and social work activities
Medical Devices
Human health activities
Country / HQ
South Africa